Cargando…
Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway
CONTEXT: Yang-Yin-Jie-Du Decoction (YYJDD) was used to improve gefitinib efficacy in our clinical practice, but its mechanism remains unclear. OBJECTIVE: This study explored if YYJDD could reverse gefitinib resistance. MATERIALS AND METHODS: H1975 cells were exposed to control, 10 μM gefitinib, 3.2 ...
Autores principales: | Chen, Shu-yi, Zhang, Gao-chen-xi, Shu, Qi-jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462892/ https://www.ncbi.nlm.nih.gov/pubmed/34543169 http://dx.doi.org/10.1080/13880209.2021.1972122 |
Ejemplares similares
-
NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/mTOR phosphorylation
por: Sun, Zhihua, et al.
Publicado: (2015) -
Composition and Bioactivity of a Modified Huang-Lian-Jie-Du Decoction
por: Lin, Mei-Yi, et al.
Publicado: (2022) -
Intermodule Coupling Analysis of Huang-Lian-Jie-Du Decoction on Stroke
por: Wang, Pengqian, et al.
Publicado: (2019) -
Checkpoint yin and yang
por: Katsnelson, Alla
Publicado: (2007) -
Analysis of Antidepressant Activity of Huang-Lian Jie-Du Decoction Through Network Pharmacology and Metabolomics
por: Qu, Shu-Yue, et al.
Publicado: (2021)